This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare
3 Hospital Stocks That Crushed S&P 500 YTD, Set to Rise Further
by Srijita Guha
High patient volumes, mergers and buyouts, and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH.
Tenet Healthcare (THC) Soars 95.8% YTD: More Room to Run?
by Zacks Equity Research
Banking on a solid guidance, enhanced portfolio and strategic measures, Tenet Healthcare (THC) holds enough potential to reap benefits for investors.
Encompass Health (EHC) Unveils 40-Bed Hospital Plan in Ohio
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct an inpatient rehabilitation hospital in Ohio, which aims to facilitate improved rehabilitation services throughout the state.
Acadia (ACHC) & SCL Health Form JV, Mark 15th Partnership
by Zacks Equity Research
Acadia Healthcare's (ACHC) JV with SCL Health is likely to build a 144-bed freestanding behavioral health unit in the Denver area.
Encompass Health (EHC) Boosts Texas Presence With Hospital Plan
by Zacks Equity Research
Encompass Health (EHC) aims to deliver better health outcomes by revealing plans to build an inpatient rehabilitation hospital in Texas.
HCA Healthcare (HCA) to Build New Hospitals in Florida
by Zacks Equity Research
HCA Healthcare (HCA) to establish further dominance in the Florida region with new acute care facilities.
Tenet (THC) Up 11.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ensign Group (ENSG) Buys Facilities to Boost Real Estate Suite
by Zacks Equity Research
Ensign Group (ENSG) acquires five skilled nursing and assisted living facilities in three U.S. states. The move underscores ENSG's efforts to grow its real estate portfolio and boost U.S. presence.
Tenet Healthcare (THC) Offers Senior Secured Notes of $1.45B
by Zacks Equity Research
Tenet Healthcare (THC) issues senior notes to procure funds. The move further highlights THC's sound financial position.
Molina Healthcare (MOH) Offers $750M, 3.875% Senior Notes
by Zacks Equity Research
Molina Healthcare (MOH) shows discretion in issuing senior notes amid a low-interest rate environment, which in turn, will procure funds.
Encompass Health (EHC) Set to Widen Presence in South Carolina
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct a 27-bed hospital in South Carolina aimed at providing high-quality rehabilitative care throughout the state.
Tenet Healthcare (THC) and USPI Strike SurgeryCenter Deal
by Zacks Equity Research
Tenet Healthcare (THC) along with its subsidiary to acquire SurgCenter Development (SCD) for $1.2 billion.
Magellan (MGLN) Q3 Earnings Decline Y/Y on Elevated Costs
by Zacks Equity Research
Magellan Health's (MGLN) third-quarter results reflect impact of rising expenses, partly offset by top-line growth and net new business growth in the Healthcare segment.
Humana's (HUM) Earnings Beat Estimates in Q3, Surge Y/Y
by Zacks Equity Research
Humana's (HUM) Q3 results reflect a better revenue stream and strength in its Retail and Healthcare Services segments.
Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare Corp. and Acadia Healthcare Company
by Zacks Equity Research
Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare Corp. and Acadia Healthcare Company
MEDNAX's (MD) Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
MEDNAX's (MD) third-quarter results reflect growing revenues driven by rising patient volumes, partly offset by higher general and administrative expenses.
4 Hospital Stocks to Gain From Rebounding Patient Volumes
by Zacks Equity Research
Expanding patient volumes, use of telehealth services, cost-control measures and an aging demography are tailwinds to the hospital industry players like HCA, UHS, THC and ACHC.
Community Health's (CYH) Q3 Earnings Beat, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) third-quarter earnings gain from a solid revenue stream and lower expenses.
Molina Healthcare's (MOH) Q3 Earnings Beat Mark, Fall Y/Y
by Zacks Equity Research
Molina Healthcare (MOH) Q3 earnings gain from better revenues, partly offset by steep expenses.
Ensign Group (ENSG) Q3 Earnings Meet, '21 Earnings Guidance Up
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter earnings gain from improved revenues, partly offset by steep expenses.
Teladoc Health (TDOC) Q3 Loss Narrower Than Expected, Down Y/Y
by Zacks Equity Research
Teladoc Health's (TDOC) third-quarter results indicate improved revenues owing to higher access fees and visit fees, partly offset by elevated costs.
Can Tenet (THC) Climb 25% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 25.3% upside potential for Tenet (THC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Universal Health (UHS) Q3 Earnings Miss Mark, Decline Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results reflect high expenses, partly offset by better revenues.
4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes
by Srijita Guha
Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.